RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $629,475 | +57.6% | 27,452 | +13.3% | 0.00% | – |
| Q2 2023 | $399,471 | +296.6% | 24,225 | +329.1% | 0.00% | – |
| Q1 2023 | $100,725 | -38.7% | 5,646 | 0.0% | 0.00% | – |
| Q4 2022 | $164,412 | -93.7% | 5,646 | -97.5% | 0.00% | -100.0% |
| Q1 2022 | $2,616,000 | +879.8% | 227,114 | +748.9% | 0.00% | – |
| Q4 2021 | $267,000 | -23.3% | 26,754 | +0.4% | 0.00% | – |
| Q3 2021 | $348,000 | -40.5% | 26,639 | -10.8% | 0.00% | – |
| Q2 2021 | $585,000 | -29.9% | 29,876 | -23.8% | 0.00% | – |
| Q1 2021 | $834,000 | +7.6% | 39,229 | +50.5% | 0.00% | – |
| Q4 2020 | $775,000 | +85.0% | 26,058 | +34.8% | 0.00% | – |
| Q3 2020 | $419,000 | +4.5% | 19,328 | +7.3% | 0.00% | – |
| Q2 2020 | $401,000 | +152.2% | 18,012 | +72.5% | 0.00% | – |
| Q1 2020 | $159,000 | -67.9% | 10,441 | -51.7% | 0.00% | – |
| Q4 2019 | $495,000 | +243.8% | 21,619 | +222.4% | 0.00% | – |
| Q3 2019 | $144,000 | -48.9% | 6,705 | -48.1% | 0.00% | – |
| Q2 2019 | $282,000 | +9.3% | 12,913 | +36.1% | 0.00% | – |
| Q1 2019 | $258,000 | +98.5% | 9,485 | +94.8% | 0.00% | – |
| Q4 2018 | $130,000 | -97.8% | 4,869 | -97.6% | 0.00% | -100.0% |
| Q3 2018 | $5,799,000 | +82.6% | 198,848 | +95.6% | 0.00% | +100.0% |
| Q2 2018 | $3,176,000 | +1405.2% | 101,648 | +854.6% | 0.00% | – |
| Q1 2018 | $211,000 | -61.1% | 10,648 | -43.2% | 0.00% | – |
| Q4 2017 | $542,000 | – | 18,733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |